Spots Global Cancer Trial Database for central nervous system diseases
Every month we try and update this database with for central nervous system diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer | NCT05386108 | Breast Neoplasm... Brain Neoplasms Neoplasms by Si... Neoplasms Breast Diseases Central Nervous... Brain Diseases Central Nervous... | Elacestrant Abemaciclib | 18 Years - | Stemline Therapeutics, Inc. | |
| Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients | NCT03147989 | Central Nervous... Central Nervous... | MultiHance | 2 Years - | Bracco Diagnostics, Inc | |
| Dexmedetomidine for Prevention of Postoperative Delirium After Intracranial Operation for Brain Tumor | NCT04399343 | Central Nervous... | Dexmedetomidine Normal saline | 18 Years - | Capital Medical University | |
| Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/HER2- Breast Cancer | NCT05386108 | Breast Neoplasm... Brain Neoplasms Neoplasms by Si... Neoplasms Breast Diseases Central Nervous... Brain Diseases Central Nervous... | Elacestrant Abemaciclib | 18 Years - | Stemline Therapeutics, Inc. | |
| Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor | NCT04494828 | Central Nervous... | Dexmedetomidine Normal saline g... | 18 Years - | Capital Medical University | |
| Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients | NCT03147989 | Central Nervous... Central Nervous... | MultiHance | 2 Years - | Bracco Diagnostics, Inc | |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical | |
| A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases | NCT00649207 | Brain Diseases Brain Neoplasms Central Nervous... Neoplasm Metast... Nervous System ... | ABT-888 Whole Brain Rad... | 18 Years - 99 Years | AbbVie | |
| DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas | NCT00805376 | Brain Cancer Central Nervous... | DNX-2401 Tumor Removal | 18 Years - | DNAtrix, Inc. | |
| Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients | NCT03147989 | Central Nervous... Central Nervous... | MultiHance | 2 Years - | Bracco Diagnostics, Inc | |
| Dexmedetomidine for Prevention of Postoperative Delirium After Intracranial Operation for Brain Tumor | NCT04399343 | Central Nervous... | Dexmedetomidine Normal saline | 18 Years - | Capital Medical University | |
| Is Sphenopalatine Ganglion Block Treatment Effective on Postspinal Headaches | NCT03512977 | Headache Disord... Central Nervous... | sphenopalatine ... conservative tr... | 18 Years - 45 Years | Derince Training and Research Hospital | |
| DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors | NCT02197169 | Glioblastoma or... | Single intratum... Interferon-gamm... | 18 Years - | DNAtrix, Inc. | |
| Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation | NCT05321498 | Mild Cognitive ... Alzheimer Disea... Dementia Brain Diseases Central Nervous... Nervous System ... Tauopathies Neurodegenerati... Mental Disorder... | XPro1595 Placebo | 55 Years - 80 Years | Inmune Bio, Inc. | |
| Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs | NCT03750188 | Central Nervous... Central Nervous... | ProHance | 1 Day - 2 Years | Bracco Diagnostics, Inc | |
| Impact Dexmedetomidine on Postoperative Delirium in Patients After Intracranial Operation for Brain Tumor | NCT04494828 | Central Nervous... | Dexmedetomidine Normal saline g... | 18 Years - | Capital Medical University | |
| Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation | NCT05321498 | Mild Cognitive ... Alzheimer Disea... Dementia Brain Diseases Central Nervous... Nervous System ... Tauopathies Neurodegenerati... Mental Disorder... | XPro1595 Placebo | 55 Years - 80 Years | Inmune Bio, Inc. | |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical | |
| Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma | NCT01081223 | Glioma High Grade Astr... Glioblastoma Mu... | Cancer vaccine ... | 18 Years - | TVAX Biomedical |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
